STOCK TITAN

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in the 2024 Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, November 19, 2024, at 12:00 p.m. GMT (7:00 a.m. ET).

Interested parties can access a live webcast of the presentation through the Investors section of Kiniksa's website at www.kiniksa.com. A replay will be made available on the company's website within 48 hours after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – KNSA

-1.61%
1 alert
-1.61% News Effect

On the day this news was published, KNSA declined 1.61%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12:00 p.m. Greenwich Mean Time (7:00 a.m. Eastern Time).

A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ®

Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com


FAQ

When is Kiniksa Pharmaceuticals (KNSA) presenting at the Jefferies London Healthcare Conference 2024?

Kiniksa Pharmaceuticals will present on Tuesday, November 19, 2024, at 12:00 p.m. GMT (7:00 a.m. Eastern Time).

How can I watch Kiniksa Pharmaceuticals' (KNSA) presentation at the Jefferies Conference?

The presentation can be viewed via live webcast through the Investors section of Kiniksa's website at www.kiniksa.com.

Will there be a replay available of Kiniksa's (KNSA) Jefferies Conference presentation?

Yes, a replay will be available on Kiniksa's website within 48 hours after the event.

What type of presentation will Kiniksa Pharmaceuticals (KNSA) give at the Jefferies Conference?

Kiniksa's management will participate in a fireside chat format presentation.
Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

KNSA Latest News

KNSA Latest SEC Filings

KNSA Stock Data

3.62B
43.67M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United Kingdom
LONDON